Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

NCT05834270 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.

NCT NCT05834270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05834270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Lead sponsor
Menoufia University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2022
Completion date
December 1, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate disease, prostate hypertrophy, prostate obstruction, prostatic neoplasms